INTRODUCTION
Civet is the glandular secretion of civet cats (Family : Viverridae), the perineal glands of which open beneath the base of its tail in to a large pouch in which a "honey like" secretion accumulates, which when fresh in pale yellow in colour, but becomes viscous black waxy mass with an unimaginable obnoxious stink.
Still civet is an irreplaceable essential substance as fixative for the most expensive perfumes, giving them life and lift. Besides its invaluable use in the perfume industry it has been attributed with certain medicinal properties also. A survey of the ayurvedic literature reveals that civet when applied externally removes localized pains and itching sensations and is useful in scabies, pimples and other skin infections. Internally it is useful in mental retardation, insanity, fainting and convulsions. It is also useful in colic pains, asthma, cough and other respiratory troubles. It removes palpitation of heart and is used in cardiac weakness 1, 2 . But no systematic pharmacological study has been undertaken to explore its therapeutic potentialities. Hence it was thought worth while to carry out the pharmacological screening of civet in detail and the preset work deals with its actions on the Central Nervous System.
MATERIALS AND METHODS
The material for the present study was a pooled sample of civet collected throughout the year from the male species of Malabar civet cat (Moschothera civettina Blyth) kept in captivity in the animal house of the Medical Collect, Trivandrum.
Preparation of the test drug:
Unless otherwise stated, for all these experiments, weighed quantity of the civet sample was thoroughly mixed with warm 3% Tween -80 solutions (aqueous) to form a fine suspension.
Albino mice of Swiss strain (25 to 35 gms) and albino rats of Holtzman strain (100 to 150g) of either sex were used for all these experiments unless mentioned otherwise.
a) Acute toxicity studies :
Graded doses of civet (100 mg, 200mg, 400 mg and 800 mg/kg) was administered orally to groups of 10 mice each. Another group serving as vehicle control received 3% Tween -80 solution orally. These animals were watched at intervals of 30 min up to 4h and then after 24h, 48h, 72h and finally after one week for any toxic manifestations or mortality.
b) Effect on behavioural pattern:
The behavioural effects were studied after oral administration of civet in the above doses with the same vehicle control using 10 mice in each group.
c) Potentiation of pentobarbital induced hypnosis:
Aqueous solution of phentobarbital sodium (40 mg/kg) was injected intraperitoneally to groups of 20 mice each, 30 min after oral administration of civet (25 mg, 50 mg, 100mg, and 200mg/kg) or 3% Tween -80 solution or water. The period between the loss and return of righting reflex was taken as sleeping time. This experiment was performed at a room temperature of 27 o C.
d) Analgesic effect:

I. Tail flick method:
Analgesic activity was tested by using albino rats by the Tail flick method. 
II. Acetic acid induced writhing test:
The method employed was that of Witkin at al3. Male albino mice were made to writhe by an intraperitoneal injection of 300 mg/kg of 3% v/v aqueous acetic acid. Civet (100mg, 20mg and 400mg/kg) and 3% Tween -80 solution were given orally 30min prior to the administration of acetic acid. Groups of 10 mice were employed. Each mouse was put in a circular glass through (100 x 190 mm) and the total number of stretching episodes for 30 min were recorded. Acetyl salicyclic acid (100 mg/kg) was administrated orally to one group of animals which served as the reference standard. Effect of the test drug was evaluated by the decrease in the number of stretching episodes over that of the vehicle control group.
e) Hypothermic effect:
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Albino mice were employed for this experiment. Civet (100 mg, 200 mg and 400 mg/kg or 3% Tween -80 solution or chlorpromazine Hcl (2.5 mg/kg) were administered orally to groups of six animals. Rectal temperature of these animals were recorded before and then at every 30min for 2h and then at 3h and 4h after the administration of drugs or solvent. These experiments were conducted at a room temperature of 27 o C.
In another set of experiments, the effect of civet on chlorpromazine induced hypothermia in mice was studied. Civet (100 mg/kg) was administered orally to mice 30 min after the administration of chlorpormazien (2.5 mg/kg p.o). Rectal temperature of these animals were noted as in the previous experiment.
f) Antipyretic effect:
Albino rats were made febrile by a sub cutaneous injection of 15% brewers yeast in 2% gum acacia in normal saline. Those rats which showed a rise of atleast 2 o F from the normal temperature before yeast injection were only selected for drug testing. They were divided into groups of 6 animals each. Civet in doses of 200 mg and 400 mg/kg were administered orally to the first two groups. Next three groups received water, 3% Tween -80 solution and acetyl salicylic acid (100 mg/ kg orally).
Rectal temperature was recorded initially and at 30 min interval for the first 2hr and thereafter at 1h interval for 2 more hours after drug treatment. Results were analysed using students 't' test.
g) Anticonvulsant effect:
I. Electroconvulsions:
This was studied in albino rats by the supramaximal electroshock seizure pattern test using Techno model convulsiometer according to the method of Holland et a l4 . The electroshock (150 mA for a duration of 0.2 secs) was delivered through ear electrodes and the duration of tonic extensor phase was recorded. Civet (100mg, 200mg, 400mg and 800mg/kg) was administered orally to these animals one hour before they were subjected to electro shock. One group of animals received 3% Tween 80 solution while another group received Dilantin sodium (20mg/kg) orally which served as reference standard. Prevention or reduction in the duration of tonic extensor phase was taken as the criteria for anticonvulsant.
II. Metrazol induced seizures:
Anticonvulsant activity was determined by the method of Swinyard et al 5 . Civet (100mg, 200mg and 400mg/kg) was administered to different groups of mice one hour before the subcutaneous injection of metrazol (100mg/kg). One group received phenobarbitone sodium (25mg/kg) orally while another group received 3% Tween -80 solution which served as the vehicle control. The number of animals protected in each group was recorded and anticonvulsant activity was represented as percent protection.
h) Effect on conditional avoidance response (CAR) and Escape response (E. R.) in trained rats:
The method employed was similar to that of Cook and Weidley 6 with minor modifications using male albino rats. Two types of responses were studied conditioned avoidance response in which the animal climbed the pole of hearing the buzzer and the escape response in which the animals escaped by climbing the pole only after receiving the shock. The animals were divided into six groups. Civet (50mg, 100mg, and 200mg and 400mg/kg), was administered orally to the first four groups, while the fifth and sixth group received chlorpromazine.
Hcl (5mg/kg and 3% Tween -80 solution orally respectively. They were examined before and at intervals of 30 min after the administration of test drugs for the first 2h and then at intervals of 1h for the next 3h for the exhibition of the above two responses.
The same study was extended to find out the effect of civet (200mg and 400mg/kg) on chlorpromazine treated (5mg/kg orally) trained rats in blocking the conditioned avoidance response by administering orally 30 min after oral administration of chlorpromazine. Other experimental details were same as in the above case.
i) Effect on "rota -rod test":
This was performed according to the method of Janssen et al7. Albino mice were placed on a horizontal rotating road having a diameter of 32mm and rotating at the rate of 5 revolutions per minute. Animals which remained on the rod for 3 or more minutes in two successive trials were selected and placed in groups of five. Civet in doses of 100, 200, 400 and 800 mg/kg were administered to different groups and they were placed on the rod at intervals of 30, 60, 90, 120 and 150 min after drug administration. If an animal failed more than once to remain on the rod for 3 min the test was considered positive, that is producing motor inco-ordination.
j) Effect on amphetamine toxicity in aggregated mice:
This was studied by the method suggested by Burn 
RESULTS a) Acute toxicity studies:
Civet when administered orally in doses of 100mg, 200mg, 400mg and 800mg/kg neither produced any toxic manifestations nor mortality in albino mice up to a period of one week. Its LD50 could not be found out since even in the 800 mg/kg dose there was no mortality and the preparation of the test drug in higher concentration was difficult.
b) Effect on behavioural pattern:
Signs of increasing CNS depression was observed in animals treated with 200mg, 400mg and 800 mg/kg of civet orally as evidenced by increased sedation, ptosis and decreased motility. No such effect was observed in control animals treated with the solvent (3% tween -80 solution) in the same quantity.
c) Potentiation of pentobarbital induced hypnosis:
Three percent Tween -80 solutions as well as civet in doses of 25 mg/kg and 50 mg/kg orally failed to produce any significant change in the Pentobarbital (40mg/kg i.p) induced hypnosis. But in higher doses (100mg and 200mg/kg orally) civet potentiated this action significantly (Table  I) . <0.02
TABLE -I Effect of Civet on Hypnosis due to Pentobarbital (40 mg/kg) in Albino Mice
Group
<0.01
Group II was compared with group I and groups III, IV, V and VI were compared with group II for statistical significance.
N. S. : Not significant d) Analgesic effect
I. Tail flick method:
Civet in doses of 25 mg and 50mg/kg orally failed to produced any analgesic effect in rats when treated by this method. But in higher doses (100 mg and 200 mg/kg p.o) mild analgesic activity was exhibited by this drug as evidenced by a significant increase in the reaction time. Maximum activity was noted 60 min after oral administration of the test drug (Table II) . 
TABLE -II Analgesic Effect of Civet as Tested by Tail Flick Method in Rats
Group
II. Acetic acid induced writhing test:
In acetic acid induced writhing test civet in doses of 200 mg and 400mg/kg orally showed significant analgesic activity. The activity produced by 400 mg/kg was comparable to that of acetylsalisylic acid (100 mg/kg p.o). (Table III) . Group II was compared with group I and groups III, IV, V and VI were compared with group II for statistical significance.
TABLE -III
N. S. : Not significant e) Hypothermic action
Civet in doses of 200mg and 400mg/kg orally produced no significant hypothermic effect in normal mice. Moreover it failed to influence the hypothermic effect produced by chlorpromazine (2.5 mg / kg p.o) in a dose of 100 mg/kg orally.
f) Antipyretic effect
Civet in doses of 200 mg and 400 mg/kg failed to exhibit any antipyretic effect in febrile rats.
g) Anticonvulsant effect:
I. Electroconvulsions:
Civet in does of 200mg, 400 mg and 800mg/kg (p.o) was found to produce significant anticonvulsant effect in rats subjected to Maximal Electroshock seizures (MES). Vehicle control (3% Tween -80 solution) as well as civet in a lower dose (100mg/kg) failed to produce this effect (Table IV) . Group III was compared with group I and groups III, IV, V, IV and VII were compared with group II for statistical significance.
TABLE -IV
Effect of Civet on Electro convulsions in rats
N. S. : Not Significant.
II. Metrazol induced convulsions:
In metrazol induced convulsions the percentage protection afforded by civet in doses of 100mg, 200mg and 400mg/kg orally was found to be 10%, 40% and 40%
respectively. Phenobarbitone (25mg/kg) produced 40% protection while 3% Tween -80 solution failed to produce any protection in these animals (Table V) . Civet in does of 100, 200, 400 and 800mg/kg failed to produce any effect on the "rota-rod" test.
j) Effect on amphetamine toxicity in aggregated mice:
Civet in doses of 100, 200, 400 and 800mg/kg failed to influence the amphetamine toxicity in aggregated mice.
DISCUSSION
The present investigation has shown that civet in varying doses increased CNS depression (as evidenced by sedation, ptosis and lesser motility), produced analgesic activity, potentiated pentobarbitone sodium induced hypnosis and exhibited anticonvulsant activity. But it failed to produce hypothermia in mice and antipyretic effect in febrile rats. It also failed to block "Conditioned avoidance response" in trained rats and did not influence chlorpromazine induced blockage of "CAR". In "Rota-rod test" civet did not produce motor incoordination in mice.
It also failed to influence amphetamine toxicity in aggregated mice. In acute toxicity studies civet upto a dose of 800 mg/kg orally was found to be non toxic. Its LD 50 could not be found out since even with the dose of 800 mg/kg there was no mortality and the preparation of higher concentration of this drug was difficult. From these observations it is presumed that the effect of civet on the central nervous system is more or less like that of a barbiturate rather than a tranquilliser. However the Ayurvedic use of civet in insanity can be partially attributed to its sedative properties.
Normally tranquillisers block conditioned avoidance response in trained rats, produce hypothermia and motor inco -ordination and decrease amphetamine toxicity in aggregated mice. But civet failed to exhibit these effects even thought it produced lesser motility and potentiated pentobarbitone induced hypnosis similar to tranquillisers. The anticonvulsant property exhibited by civet gives more support for this conclusion. The substances which depresses Central Nervous System have a variety of manifestations. Since the mildest of these is tranquillisation the tests for tranquillising agents and some of the Central Nervous System depressants overlap. Hence more work has to be done in order to confirm its mechanism of action.
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